跳至主要内容
临床试验/CTRI/2019/08/020894
CTRI/2019/08/020894招募中未知

Role of Levothyroxine on progression of Chronic Kidney Disease in subclinical hypothyroid populations - A multicentric randomized controlled trial - LP-CKD

ICMR0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. CKD with eGFR > 14 ml/min/1.73m2 with any degree of albuminuria. We will stratify enrollment, aiming at-least 30% in each stage 2,3&4 CKD.

排除标准

  • 1. Age <18 or >65 years
  • 2. Uncontrolled diabetes
  • 3. uncontrolled hypertension
  • 4. malignancy.
  • 5. Unstable renal course or AKI in last three months
  • 6. History recurrent UTI
  • 7. Obstructive uropathy or structural disease of kidney or renal tract
  • 8. History of analgesics abuse, alternative medication and nephrotoxic agents in past 3 months.
  • 9. Cardiac and liver dysfunction
  • 10. Kidney transplant recipients.

研究者

发起方
ICMR

相似试验